ADAMS R MARK
SEC CIK 1808905 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | COO | 177.7K | — | $581.2K | 12 | 2021-07-07 | 2023-04-10 |
Most active insiders at ADPT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROBINS CHAD M | CEO, COB, Dir | — | $39.80M |
| 2 | ROBINS HARLAN S | CSO | — | $29.65M |
| 3 | BENZENO SHARON | Chief Commercial Ofc Imm Med | — | $14.69M |
| 4 | RUBINSTEIN JULIE | Pres, COO | — | $13.37M |
| 5 | LO FRANCIS | CHRO | — | $13.21M |
| 6 | PISKEL KYLE | CFO | — | $3.58M |
| 7 | NEUPERT PETER M | Dir | — | $3.14M |
| 8 | GRIFFIN MICHELLE RENEE | Dir | — | $2.00M |
| 9 | BOBULSKY SUSAN | Chief Commercial Off, MRD | — | $1.20M |
| 10 | HERSHBERG ROBERT | Dir | — | $1.12M |
ADAMS R MARK made no open-market trades at ADPT in the last 12 months.
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-04-12 | 2023-04-10+ | ADPT | Adaptive Biotechnologies Corp | ADAMS R MARK | COO | S - Sale | $8.60 | -3,125 | 177.7K | -2% | -$26.9K |
| DM | 2023-03-08 | 2023-03-06+ | ADPT | Adaptive Biotechnologies Corp | ADAMS R MARK | COO | S - Sale | $8.59 | -23.7K | 195.6K | -11% | -$203.5K |
| D | 2023-03-08 | 2023-03-06 | ADPT | Adaptive Biotechnologies Corp | ADAMS R MARK | COO | A - Grant | $0.00 | +88.7K | 202.2K | +78% | $0 |
| M | 2023-01-11 | 2023-01-09+ | ADPT | Adaptive Biotechnologies Corp | ADAMS R MARK | COO | S - Sale | $8.55 | -3,125 | 115.6K | -3% | -$26.7K |
| M | 2022-10-11 | 2022-10-07+ | ADPT | Adaptive Biotechnologies Corp | ADAMS R MARK | COO | S - Sale | $7.26 | -3,125 | 116.6K | -3% | -$22.7K |
| M | 2022-07-08 | 2022-07-07+ | ADPT | Adaptive Biotechnologies Corp | ADAMS R MARK | COO | S - Sale | $10.22 | -3,125 | 122.1K | -2% | -$31.9K |
| 2022-04-08 | 2022-04-07 | ADPT | Adaptive Biotechnologies Corp | ADAMS R MARK | COO | S - Sale | $13.17 | -831 | 122.9K | -0.7% | -$10.9K | |
| D | 2022-03-08 | 2022-03-07 | ADPT | Adaptive Biotechnologies Corp | ADAMS R MARK | COO | S - Sale | $12.01 | -1,244 | 123.7K | -1.0% | -$14.9K |
| D | 2022-03-08 | 2022-03-04 | ADPT | Adaptive Biotechnologies Corp | ADAMS R MARK | COO | A - Grant | $0.00 | +74.1K | 125.0K | +146% | $0 |
| 2022-01-10 | 2022-01-07 | ADPT | Adaptive Biotechnologies Corp | ADAMS R MARK | COO | S - Sale | $23.32 | -1,021 | 50.8K | -2% | -$23.8K | |
| M | 2021-10-08 | 2021-10-07+ | ADPT | Adaptive Biotechnologies Corp | ADAMS R MARK | COO | S - Sale | $33.16 | -3,125 | 51.9K | -6% | -$103.6K |
| M | 2021-07-08 | 2021-07-07+ | ADPT | Adaptive Biotechnologies Corp | ADAMS R MARK | COO | S - Sale | $37.17 | -3,125 | 55.0K | -5% | -$116.2K |
Purchase Sale Sale after option exercise All abbreviations